Imbalanced T-Cell Subsets May Facilitate the Occurrence of Osteonecrosis of the Femoral Head

Background Osteonecrosis of the femoral head (ONFH) is a complex disease resulting in degeneration of the hip joint. The pathogenesis of ONFH is largely unknown, but alterations in immunological factors have been proposed to play a role. Methods We included 109 patients with ONFH and 109 age-, sex-, and body mass index-matched healthy controls in this study. The percentage of circulating CD3+, CD4+, and CD8+ lymphocytes among the total lymphocytes was identified by flow cytometry and compared between the cases and controls. Subgroup analysis within each etiological group and correlation analysis of T-cell subset levels with disease duration were performed. Furthermore, we compared the expression patterns of CD4, RANKL, and FoxP3 in the femoral head of healthy and glucocorticoid (GC)-treated ONFH rats. Results The results showed that CD3+ and CD4+ T-cell counts and the CD4+/CD8+ ratio were significantly higher in patients with ONFH and that CD3+ lymphocyte levels were negatively correlated with disease duration. The CD4+ T-cell levels and CD4+/CD8+ ratios in the GC-ONFH etiological group were lower than those in the idiopathic-, traumatic-, and alcoholic-ONFH groups, while the CD8+ T-cell levels were higher. Furthermore, the CD3+, CD4+, and CD8+ T-cell counts and the CD4+/CD8+ ratio were higher in the GC-ONFH group than in the control group. Finally, we observed diminished levels of FoxP3/CD4 double-positive T regulatory cells and increased RANKL+ T-cell levels in the bone marrow of the femoral head in GC-ONFH rats. Conclusion The imbalance of T-cell subsets might be involved in the pathophysiological process of ONFH, and diminished CD4+/FoxP3+ T regulatory cells may be associated with increased RANKL+ T cells in the bone marrow of the femoral head in GC-ONFH, which may facilitate bone resorption and collapse of the femoral head. Trial Registration This study was registered in the Chinese Clinical Trial Registry (Registration number: ChiCTR2100042642).

• Publication year

  2022

• Venue

  Journal of Inflammation Research

• Publication date

  2022-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2147/JIR.S367214PMID 35912401PMCID 9328079
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Primary cutaneous diffuse large B-cell lymphoma after total knee arthroplasty: a case study and a systematic review of its cutaneous manifestations and treatment options

  2021cited by this paper
• Osteoarthritis and Osteonecrosis in Total Hip Arthroplasty: 90-Day Postoperative Costs and Outcomes.

  2020cited by this paper
• CD4+ T Cell Profile and Activation Response in Sickle Cell Disease Patients with Osteonecrosis

  2020cited by this paper
• TNF-α and IL-6: the link between immune and bone system.

  2020cited by this paper
• RETRACTED ARTICLE: Down-regulated microRNA-141 facilitates osteoblast activity and inhibits osteoclast activity to ameliorate osteonecrosis of the femoral head via up-regulating TGF-β2

  2020cited by this paper
• Mid- to long-term results of modified non-vascularized allogeneic fibula grafting combined with core decompression and bone grafting for early femoral head necrosis

  2020cited by this paper
• Drug release from pharmaceutical co-crystals: are therapeutic and safety properties of active pharmaceutical substances retained?

  2020cited by this paper
• Effects of Teriparatide Versus Salmon Calcitonin Therapy for the Treatment of Osteoporosis in Asia: A Meta-analysis of Randomized Controlled Trials.

  2020cited by this paper
• Alcohol and Smoking Mediated Modulations in Adaptive Immunity in Pancreatitis

  2020cited by this paper
• Cytokine‐regulated Th17 plasticity in human health and diseases

  2020cited by this paper
• Etiologic Classification Criteria of ARCO on Femoral Head Osteonecrosis Part 1: Glucocorticoid-Associated Osteonecrosis.

  2019influential reference
• Drug Release from Pharmaceutical Co-Crystals: Are Therapeutic and Safety Properties of Active Pharmaceutical Substances Retained?

  2019cited by this paper
• The Role of Immune Regulatory Cells in Nontraumatic Osteonecrosis of the Femoral Head: A Retrospective Clinical Study

  2019influential reference
• Cell-by-cell deciphering of T cells in allergic inflammation.

  2019cited by this paper
• Etiologic Classification Criteria of ARCO on Femoral Head Osteonecrosis Part 2: Alcohol-Associated Osteonecrosis.

  2019influential reference
• Selected signalling proteins recruited to the T‐cell receptor–CD3 complex

  2018cited by this paper
• Immunoporosis: Immunology of Osteoporosis—Role of T Cells

  2018cited by this paper
• Parathyroid Diseases and T Cells

  2017cited by this paper
• Homeostatic Expansion of CD4+ T Cells Promotes Cortical and Trabecular Bone Loss, Whereas CD8+ T Cells Induce Trabecular Bone Loss Only

  2017cited by this paper
• Prevalence of Nontraumatic Osteonecrosis of the Femoral Head and its Associated Risk Factors in the Chinese Population: Results from a Nationally Representative Survey

  2015cited by this paper
• Role of T cell reconstitution in HIV-1 antiretroviral therapy-induced bone loss

  2015cited by this paper
• Experimental animal models of osteonecrosis

  2011cited by this paper
• Prominent Bone Loss Mediated by RANKL and IL-17 Produced by CD4+ T Cells in TallyHo/JngJ Mice

  2011cited by this paper
• Role of CD3ε-mediated signaling in T-cell development and function.

  2011cited by this paper
• The natural history of untreated asymptomatic osteonecrosis of the femoral head: a systematic literature review.

  2010cited by this paper
• Synovial Inflammation in Patients with Osteonecrosis of the Femoral Head

  2009cited by this paper
• Treg cells suppress osteoclast formation: a new link between the immune system and bone.

  2007cited by this paper
• Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

  2006cited by this paper
• Th17: an effector CD4 T cell lineage with regulatory T cell ties.

  2006cited by this paper
• Immunologic factors in the pathogenesis of osteonecrosis.

  2004cited by this paper
• Faculty Opinions recommendation of Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes.

  2003cited by this paper
• Identification of the β cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes

  2003cited by this paper
• Activated T lymphocytes support osteoclast formation in vitro.

  1999cited by this paper
• Lymphocyte subsets of the nasal mucosa in perennial allergic rhinitis.

  1995cited by this paper

• Selenium Attenuates Dexamethasone‐Induced Osteoblast Dysfunction and Prevents Femoral Head Osteonecrosis via PI3K/AKT/GSK3β Pathway Activation

  2025cites this paper
• Hierarchical spatiotemporal delivery system reprograms osteoclast subtypes to promote angiogenesis and bone regeneration in steroid-induced osteonecrosis of the rat femoral head

  2025cites this paper
• Scaffold-Mediated Microenvironmental Modulation Targeting Osteoclasts for ONFH Niche Reprogramming

  2025cites this paper
• M2 macrophages-derived exosomes for osteonecrosis of femoral head treatment: modulating neutrophil extracellular traps formation and endothelial phenotype transition

  2025cites this paper
• Osteoimmunology: Crosstalk Between T Cells and Osteoclasts in Osteoporosis

  2025cites this paper
• Immunological mechanisms in steroid-induced osteonecrosis of the femoral head

  2025cites this paper
• Mediating Effects of Immunophenotypes on the Causal Relationship of Gut Microbiota and Their Metabolic Pathways With Osteonecrosis: A Mendelian Randomization Analysis

  2025cites this paper
• Exploring the alteration of gut microbiota in the rats with steroid-induce osteonecrosis of the femoral head

  2025cites this paper
• Translational horizons in stem cell therapy for osteonecrosis of the femoral head: a journey from basic research to clinical practice through bibliometric insights

  2024cites this paper
• Regulation of macrophage polarization and pyroptosis by 4-methylcatechol alleviates collagen-induced arthritis via Nrf2/HO-1 and NF-κB/NLRP3 signaling pathways.

  2024cites this paper
• Clinical Characteristics, Current Treatment Options, Potential Mechanisms, Biomarkers, and Therapeutic Targets in Avascular Necrosis of Femoral Head

  2024cites this paper
• Machine learning‐mediated identification of ferroptosis‐related genes in osteonecrosis of the femoral head

  2024cites this paper
• [Role and mechanism of macrophage-mediated osteoimmune in osteonecrosis of the femoral head].

  2024cites this paper
• Complex causal association between genetically predicted 731 immunocyte phenotype and osteonecrosis: a bidirectional two-sample Mendelian randomization analysis

  2024cites this paper
• Identification of microtubule-associated biomarker using machine learning methods in osteonecrosis of the femoral head and osteosarcoma

  2024cites this paper
• Lithium Promotes Osteogenesis via Rab11a-Facilitated Exosomal Wnt10a Secretion and β-Catenin Signaling Activation.

  2024cites this paper
• Proximal Femoral Metastasis From Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma Mimicking Osteosarcoma on Magnetic Resonance Imaging

  2024cites this paper
• Exploring the genetic association between immune cells and susceptibility to osteonecrosis using large-scale population data

  2024cites this paper
• Comprehensive analysis of femoral head necrosis based on machine learning and bioinformatics analysis

  2023cites this paper
• Ankylosing spondylitis complicated with traumatic thoracic fracture dislocation with old spinal cord injury

  2023cites this paper
• Engineered Exosome-Functionalized Extracellular Matrix-Mimicking Hydrogel for Promoting Bone Repair in Glucocorticoid-Induced Osteonecrosis of the Femoral Head.

  2023cites this paper